ArticleNature communications2018
Monitoring the action of redox-directed cancer therapeutics using a human peroxiredoxin-2-based probe.
Troy F Langford et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
21 papers cite it
this papercites it